Concepedia

Publication | Open Access

Multicenter longitudinal study of B-lymphocyte depletion in refractory systemic lupus erythematosus: the LESIMAB study

DOIFull Paper Access

113

Citations

34

References

2012

Year

Antonio Fernández‐Nebro, JL Marenco de la Fuente, Luis Carreño, María Galindo-Izquierdo, Eva Tomero, Íñigo Rúa‐Figueroa, B. Hernández-Cruz, Javier Narváez, Alejandro Olivé, Antonio Zea,
Lupus

Abstract

Rituximab can be an effective treatment option for patients who have refractory lupus with severe or life-threatening disease with an acceptable tolerance profile.

References

YearCitations

Page 1